Reuters |
Pfizer to buy Allergan in $160 billion deal
Reuters NEW YORK Pfizer Inc on Monday said it would buy Botox maker Allergan Plc in a deal worth $160 billion to slash its U.S. tax bill, rekindling a fierce political debate over the financial maneuver. The acquisition, which would shift Pfizer’s headquarters … Pfizer gobbles up tax advantages in a turkey of a transactionWashington Post Experts: Treasury unlikely to block Pfizer-Allergan dealUSA TODAY Don’t Hate Pfizer’s Tax InversionZacks.com International Business Times –Wall Street Journal –Morningstar all 1,272 news articles » |
Source: Google News
